111,99 €
This book helps advance process safety in a key area of interest. Currently, no literature exists which is solely dedicated to process safety for the bioprocessing industry. There are texts, guidelines, and standards on biosafety at the laboratory level and for industrial hygiene, but no guidelines for large-scale production facilities. In fact, biosafety is largely defined as a field that promotes safe laboratory practices, procedures and use of containment equipment and facilities. Additionally, biomedical engineers, biologists, or other professionals without chemical engineering training or knowledge of inherently safe design are designing many of these facilities.
Das E-Book können Sie in Legimi-Apps oder einer beliebigen App lesen, die das folgende Format unterstützen:
Veröffentlichungsjahr: 2011
CONTENTS
Cover
Half Title page
Title page
Copyright page
List of Tables
List of Figures
Files on the Web Accompanying This Book
Acknowledgements
Preface
Chapter 1: Introduction
1.1 Bioprocess Engineering Information Transfer and Management Practices
1.2 The Need for Bioprocess Safety Management Systems
1.3 Our Target Audience
1.4 How to Use this Guideline
Chapter 2: An Overview of the Bioprocessing Industry
2.1 Bioprocessing’s History
2.2 Industrial Applications
2.3 The Bioprocess Lifecycle
Chapter 3: Bioprocessing Safety Management Practices
3.1 Sample Approach
3.2 Existing Management Systems
3.3 Establishing a Bioprocess Safety Management System
3.4 Biosafety Training for the Workforce
3.5 Investigating Incidents
3.6 Managing Change
3.7 Reviewing and Auditing for Continuous Improvement
3.8 Applying Behavior-Based Safety to Bioprocesses
Chapter 4: Identifying Bioprocess Hazards
4.1 Key Considerations for Assessing Risk to Manage Bioprocess Safety
4.2 Bioprocess Risk Assessment
4.3 Recombinant Organisms
4.4 Cell Culture
Chapter 5: Bioprocess Design Considerations and Unit Operations
5.1 Physical Plant Design
5.2 Bioprocess Unit Operations
Chapter 6: The Effects of Emerging Technology on Bioprocessing Risk Management
6.1 Researching and Staying Informed
6.2 Communicating the Impacts of New Technology
Appendix A – References & Selected Regulations
Appendix B – Large Scale Biosafety Guidelines
Appendix C – A Generic Laboratory/Large Scale Biosafety Checklist
Appendix D – Biological Assessment Questionnaire & Bioprocess Safety Checklist
Appendix E – Bioprocess Facility Audit Checklist
Appendix F – Directive 2000/54/EC of the European Parliament and of the Council
Appendix G – Comparison of Good Large Scale Practice (GLSP) and Biosafety Level (BL) - Large Scale (LS) Practice
Glossary
Acronyms and Abbreviations
Index
Guidelines for Process Safety in Bioprocess Manufacturing Facilities
This book is one in a series of process safety guideline and concept books published by the Center for Chemical Process Safety (CCPS). Please go to www.wiley.com/go/ccps for a full list of titles in this series.
It is sincerely hoped that the information presented in this document will lead to an even more impressive safety record for the entire industry. However, neither the American Institute of Chemical Engineers, its consultants, the CCPS Technical Steering Committee and Subcommittee members, their employers, their employers, officers and directors, nor AntiEntropics, Inc., and its employees warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented in this document. As between (1) American Institute of Chemical Engineers, its consultants, CCPS Technical Steering Committee and Subcommittee members, their employers, their employers, officers and directors, and AntiEntropics, Inc., and its employees and (2) the user of this document, the user accepts any legal liability or responsibility whatsoever for the consequences of its use or misuse.
Copyright © 2011 by American Institute of Chemical Engineers, Inc. All rights reserved.
A Joint Publication of the Center for Chemical Process Safety of the American Institute of Chemical Engineers and John Wiley & Sons, Inc.
Published by John Wiley & Sons, Inc., Hoboken, New Jersey.Published simultaneously in Canada.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission.
Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic format. For information about Wiley products, visit our web site at www.wiley.com.
Library of Congress Cataloging-in-Publication Data:
Guidelines for process safety in bioprocess manufacturing facilities / Center for Chemical Process Safety of the American Institute of Chemical Engineers.p. cm.Includes index.ISBN 978-0-470-25149-2 (hardback)1. Biochemical engineering—Safety measures. I. American Institute of Chemical Engineers. Center for Chemical Process Safety.TP248.3.G85 2011660.6028′9—dc22
2010036824
oBook ISBN: 978-0470-94914-6ePDF ISBN: 978-0470-94913-9
LIST OF TABLES
TABLE 1-1 Typical Hazards at Bioprocess Manufacturing Sites
TABLE 1-2 Preliminary Design Anticipated Hazards Analysis
TABLE 1-3 Incidents Related to Products of Biologic Origin
TABLE 1-4 Selected International Biosafety Levels and Acronyms
TABLE 2-1 Comparison of Process Parameters and Characteristics of Recombinant Bacterial and Mammalian Cell Lines for Production of Recombinant DNA Protein Products
TABLE 2-2 Components of Typical Growth Media
TABLE 2-3 Examples of Very Large Scale Bioprocessing Products
TABLE 3-1 Comparison of a CEN-Based Biorisk Management System to OSHA PSM, EPA RMP, and CCPS Risk-Based Process Safety (RBPS)
TABLE 3-2 A Five-phase Review and Approval Cycle
TABLE 4-1 WHO Risk Group Classifications
TABLE 5-1 Clean Room Classifications
LIST OF FIGURES
Figure 1-1 The International Biohazard Symbol
Figure 2-1 Typical Process Operations for a Bioprocess
Figure 2-2 Typical Steps to Develop rDNA E. coli
Figure 2-3 Typical Steps to Manufacture Human Insulin
Figure 2-4 Basic Biotech Manufacturing Unit Operations
Figure 2-5 The Cell Culture Scale-Up Process (Staging)
Figure 2-6 A Common Spinner Flask
Figure 2-7 Seed Bioreactors
Figure 2-8 The Cell Growth Lifecycle
Figure 2-9, Stirred-Tank Bioreactor
Figure 2-10 Large Scale Wave Bioreactor (Courtesy of GE Healthcare)
Figure 3-1 Bioprocess Hazard Management Implementation Flowchart
Figure 5-1 Nested Zones
Figure 5-2 People and Material Flow Diagram
Figure 5-3 Vaporized Hydrogen Peroxide (VHP) decontamination unit
Figure 5-4 A Wet Scrubber
Figure 5-5 Image of a Microenvironment
Figure 5-6 A Typical Glove Box
Figure 5-7 HEPA Filter Installation
Figure 5-8 Air Lock Types Pressure Differential Diagram
Figure 5-9 Full Body Positive Pressure Suit
Figure 5-10 Effluent Decontamination System
Figure 5-11 Retinal Scanning Device
Figure 5-12 Closed Disposable Sampling System
Figure 5-13 Traditional Clean Room Approach
Figure 5-14 Gray Space Approach
Figure 5-15 Minimizing Classified Space
Figure 5-16 Flow and Segregation Relationships
Figure 5-17 Clean-in-Place Hard Spots
Figure 5-18 Disk-type Centrifuge
Figure 5-19 Ultrafiltration Skid (Courtesy of Sartorius)
Figure 5-20 Chromatography Column Schematic (Courtesy of Optek)
FILES ON THE WEB ACCOMPANYING THIS BOOK
Biological Assessment Questionnaire
Bioprocess Facility Audit Checklist
You can access these files by going to the site:www.aiche.org/ccps/publications/bioprocess.aspx
To access the files, download the zipped folder and extract all of the files. You will be asked for a password, enter the password:
CCPSBio2010
If you have difficulty accessing the files, contact CCPS at ccps@aiche.org or + 1.646.495.1371
ACKNOWLEDGEMENTS
The American Institute of Chemical Engineers (AIChE) wishes to thank the Center for Chemical Process Safety (CCPS) and those involved in its operation, including its many sponsors whose funding made this project possible, and the members of the Technical Steering Committee, who conceived of and supported this guideline project. The members of the bioprocess safety management subcommittee who worked with AntiEntropics, Inc. to produce this text deserve special recognition for their dedicated efforts, technical contributions, and overall enthusiasm for creating a useful addition to the process safety guideline series. CCPS also wishes to thank the subcommittee members’ respective companies for supporting their involvement in this project as well as the American Biological Safety Association (ABSA) for creating a source for sharing valuable bioprocessing safety information and research.
The chairman of the bioprocess safety management subcommittee was Will Fleming of Bristol-Myers Squibb. The CCPS staff liaison was Dan Sliva. The members of the CCPS guideline subcommittee were:
Buddy Bowman, SyngentaRick Braun, IPSMary Cipriano, Abbott LaboratoriesAaron Duff, Bristol-Myers SquibbBruce Greer, Scientific Protein Laboratories LLCJose Hanquier, Eli Lilly and CompanyJerry Jones, GenentechBeth Junker, Merck & Company, Inc.Chantel Laing, Schering-Plough CorporationDenise Lackey, Amgen, Inc.Richard Medwid, Eli Lilly and CompanyBarbara Owen, Bristol-Myers SquibbAlan Powell, Merck & Company, Inc.Robert Stankovich, Eli Lilly and CompanyAntiEntropics, Inc. of New Market, Maryland, was the contractor for this project. Robert J. Walter was the principal co-author and project manager. Sandra A. Baker was co-author and editor. Joseph Kallhoff was a contributing author. In addition. AntiEntropics would like to recognize the following contributors:
Bob Stankovich of Eli Lilly and Company for his co-authorship of Chapter 3Mary Cipriano of Abbott Laboratories for her authorship of Chapter 4David McGlashan of Caris DX and Jeffery Odum of NC BioSource for contributing Chapter 5.CCPS also gratefully acknowledges the comments submitted by the following peer reviewers:
William Gaylord, AllerganRobert Kiss, GenentechDavid R. Maraldo, Ph.D., Merck & Company, Inc.Chris Meyer, Eli Lilly and CompanyDan Noberini, Bristol-Myers SquibbVenkata Ramana, Reliance Life Sciences Pvt. Ltd,Richard Rebar, GlaxoSmithKlineStephen Sykes, United States Food and Drug AdministrationDan Wozniak, Abbott LaboratoriesTimothy E. Woenker, Chematics, Inc.Their insights, comments, and suggestions helped ensure a balanced perspective for this guideline.
PREFACE
The American Institute of Chemical Engineers (AIChE) has been closely involved with process safety and loss control issues in the chemical and allied industries for more than four decades. Through its strong ties with process designers, constructors, operators, safety professionals, and members of academia, AIChE has enhanced communications and fostered continuous improvement of the industry’s high safety standards. AIChE publications and symposia have become information resources for those devoted to process safety and environmental protection.
AIChE created the Center for Chemical Process Safety (CCPS) in 1985 after the chemical disasters in Mexico City, Mexico, and Bhopal, India. The CCPS is chartered to develop and disseminate technical information for use in the prevention of major chemical accidents. The center is supported by more than 80 chemical process industries (CPI) sponsors who provide the necessary funding and professional guidance to its technical committees. The major product of CCPS activities has been a series of guidelines to assist those implementing various elements of a process safety and risk management system. This book is part of that series.
AIChE recognized a significant increase in members’ bioprocess related needs in the early 1990s. Some of these members’ processes benefit from traditional process safety techniques, others present different challenges for managing the biological nature of their hazards and associated risks, and still others combine both categories of hazards. Bioprocess safety management meshes the lessons learned from over 24 years of chemical process safety management with the unique approaches demanded by the widening variety of bioprocessing safety challenges. The CCPS Technical Steering Committee initiated the creation of these guidelines to assist bioprocessing facilities in meeting these challenges. This book contains approaches for designing, developing, implementing, and continually improving a bioprocess safety management system. The website accompanying this book contains resource materials and support information.
CHAPTER 1
INTRODUCTION
The following definition sets the scope of our discussion of process safety management in the bioprocess manufacturing industry:
Bioprocess—A process that makes use of microorganisms, cells in culture, or enzymes to manufacture products or complete a chemical transformation.
Humans have been using such processes for baking bread, making cheese and fermenting alcoholic beverages since prehistoric times. Advances in commercializing recombinant DNA technology allow the production of an enormous variety of protein-based therapeutic drugs that is having a profound impact on the quality of life for severely ill patients. Bioprocessing is also essential to several emerging industries and technologies, including the production of biofuels from renewable biomass feedstocks such as ethanol biodiesel, and for the production of polymeric materials. Therapeutic stem cells, gene therapy vectors, and new vaccines are all the results of bioprocessing technology.
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!